Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001144204-10-025957

Options or other derivatives

  • SVP, Chief Scientific Officer acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

FUERST THOMAS RICHARD · SVP, Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2010-05-06 Grant or award : show line 1 in the form Stock Option (right to buy) +20,000 $1.38 2020-05-06 20,000 20,000 D
Loading xslF345X03/v184299_ex.xml…